Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: A randomised, double-blind comparison

  • Mahler D
  • D'Urzo A
  • Bateman E
 et al. 
  • 80


    Mendeley users who have this article in their library.
  • 129


    Citations of this article.


Current guidelines recommend treatment with one or more long-acting bronchodilators for patients with moderate or more severe chronic obstructive pulmonary disease (COPD). The authors investigated the approach of dual bronchodilation using indacaterol, a once-daily long-acting β(2) agonist, and the long-acting muscarinic antagonist tiotropium, compared with tiotropium alone.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Donald A. Mahler

  • Anthony D'Urzo

  • Eric D. Bateman

  • Serir A. Özkan

  • Tracy White

  • Clare Peckitt

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free